Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 477, pseudogene (RNU6-477P) is classified as a pseudogene that is related in sequence to the U6 small nuclear RNA, which itself is involved in the spliceosome and pre-mRNA splicing in eukaryotic cells. As a pseudogene, RNU6-477P is not known to encode a functional product and is not considered a therapeutic target. There is no evidence linking this pseudogene to disease processes, drug interactions, or biomarker roles[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 477, pseudogene (RNU6-477P).